Hematology-Oncology
Jang, Jun Ho
95 AppointmentProfessor, Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center
Speciality Interests
Schedule
05 | MON 06 |
TUE 07 |
WEN 08 |
THU 09 |
FRI 10 |
---|---|---|---|---|---|
AM | available | available | |||
PM | available |
Medical School
2000~2002 Ph.D. in Medicine Graduate School, Yonsei University, Korea 1998~2000 Master of Science Graduate School, Yonsei University, Korea 1986~1992 College of Medicine, Yonsei University, Korea
Specialty Training
Fellowship | 2002~2004 University of Michigan Ann Arbor, USA 2000~2002 Hematology-Oncology, Severance Hospital, College of Medicine Yonsei University, Korea |
|
---|---|---|
Residency | 1999~2002 Internal Medicine, Severance Hospital, College of Medicine Yonsei University, Korea | |
Internship | 1995~1996 Severance Hospital, College of Medicine Yonsei University, Korea |
Other Education
2014~present Professor Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center
2013~2015 Chief Division of Hematology-Oncology, Samsung Medical Center
2007~2013 Associate Professor Division of Hematology-Oncology, Sungkyunkwan University School of Medicine, Samsung Medical Center
2004~2007 Clinical Instructor Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea
Participation in Academic Societies
and Research
2022~Present Director The Korean Society of blood transfusion
2019~Present Chairman of the commission The Korean Society of Hematology aplastic anemia working Party
2014~Present Director The Korean Society for patient blood management
2010~Present Member The Korean Association of internal medicine
2007~Present Member The Korean Society of Blood and marrow transplantation
1998~Present Member The Korean Society of Hematology
2000~Present Member The American Society of Hematology
2000~Present Member The European Hematology Association
Thesis
ASIA-PAC J CLIN ONCO 2021 10.1111/ajco.13609
Efficacy and safety of blinatumomab: Post hoc pooled analysis in Asian adults with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
ANN LAB MED 2021 10.3343/alm.2021.41.3.342
LSAMP Rearrangement in Acute Myeloid Leukemia With a Jumping Translocation Involving 3q13.31
KOREAN J INTERN MED 2021 10.3904/kjim.2019.385
Mutations in genes affecting DNA methylation enhances responses to decitabine in patients with myelodysplastic syndrome
J CLIN ONCOL 2021 10.1200/JCO.20.01895
Imetelstat Achieves Meaningful and Durable Transfusion Independence in High Transfusion-Burden Patients With Lower-Risk Myelodysplastic Syndromes in a Phase II Study
BRIT J HAEMATOL 2021 10.1111/bjh.17190
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study